Skip to content
ARE Alexandria Real Estate Equities Inc NYSE
119.99 USD -1.48% -1.80
OPEN 120.71
DAY RANGE 121.64 - 119.03
52 WEEK RANGE 172.65 - 110.64
Interactive Brokers Logotype

Buy ARE stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 21.1B
Enterprise value 34.9B
Trailing pe 26.591703
Forward pe 28.928741
Peg ratio 28.928741
Price to sales ttm 7.876233
Price to book mrq 1.1158346
Enterprise to revenue 13.058
Enterprise to ebitda 21.835


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.28
Operating margin 0.24490999
Return on assets ttm 0.01174
Return on equity ttm 0.04245
Income statement
Revenue ttm 2.7B
Revenue per share ttm 16.233
Quarterly revenue growth 0.139
Gross profit ttm 1.8B
Ebitda 1.7B
Net income to common ttm 740.2M
Diluted eps ttm 4.58
Quarterly earnings growth yoy 0.13938364237926
Balance sheet
Total cash mrq 1.3B
Total cash per share mrq 7.303
Total debt mrq 11.9B
Total debt to equity mrq 52.641
Current ratio mrq 4.131
Book value per share mrq 109.147
Cash flow
Operating cash flow ttm 1.4B
Levered free cash flow ttm 1.4B

Stock statistics

Shares outstanding 173M
Float shares 171.1M
Avg 10 volume 1M
Avg 30 volume 892.5K
Shares short 2.8M
Short ratio 3.13
Short percent of shares outstanding 0.019
Percent held by insiders 0.00925
Percent held by institutions 0.95763

Stock price summary

Fifty two week low 110.64
Fifty two week high 172.65
Fifty two week change -25.392
Beta 0.94546
Day 50 ma 120.1842
Day 200 ma 140.7591

Dividends and splits

Forward annual dividend rate 4.96
Forward annual dividend yield 0.042
Trailing annual dividend rate 4.78
Trailing annual dividend yield 0.040433094
5 year average dividend yield 2.71
Payout ratio 1.0437
Dividend date 2023-04-14
Ex dividend date 2023-06-29
Last split factor 1-for-1 split
Last split date 2006-04-24

Alexandria Real Estate Equities (ARE) company profile

Alexandria Real Estate Equities Inc. (NYSE: ARE) is an American company that acquires, manages, expands, and develops office and laboratory space properties. The company leases its properties to clients from pharmaceutical, biotechnology, diagnostic, personal care product research institutions, and related government entities. The firm also focuses on collaborative life science and technology campuses.